Peptide entry

Tesamorelin

Approved drugPeptide

Evidence / context

Evidence: Approved-drug context exists for a specific indication; formulation and use case matter.

Available vial formats

Tesamorelin
Vial 10 mgMix 3.0 mLConc 3.33 mg/mL
  • Conservative 1 mg once daily (30 units per injection)
  • Standard 2 mg once daily (the approved Egrifta label dose) (60 units per injection)
  • Aggressive 2 mg once daily is the established maximum; this guide does not exceed it (60 units per injection)
  • Cycle length 12-26 weeks
  • Best timing Morning fasted first; pre-bed remains an option.

Reconstitution

  1. Swab vial tops with alcohol
  2. Draw 3.0 mL bacteriostatic water
  3. Inject slowly down vial wall (don't blast powder)
  4. Gently swirl - do not shake
  5. Rest 5-10 min to dissolve
  6. Refrigerate 2-8 C

Dosing, cycle & timing

Timing: Use morning fasted as the default. Optional pre-bed fasted dosing remains an alternative. Avoid dosing near food, especially carbs, when aiming for a GH pulse.

Support / expected effects

Side effects / tolerability

Practical tips

Storage

Refrigerated: ~45-60 days.

Calculate the exact draw for TesamorelinPreloads your vial and water amount into the calculator.
Open calculator

Related peptides

Related goal guides

Related categories

FAQ

What is Tesamorelin explored for?

Visceral fat signal (slow burn). May improve lipid handling. Body comp over months.

How is Tesamorelin reconstituted?

1) Swab vial tops with alcohol 2) Draw 3.0 mL bacteriostatic water 3) Inject slowly down vial wall (don't blast powder) 4) Gently swirl - do not shake 5) Rest 5-10 min to dissolve 6) Refrigerate 2-8 C

What is a typical cycle length for Tesamorelin?

12-26 weeks

How are doses measured in syringe units here?

Units mean U-100 insulin-syringe gradations (1 mL = 100 units), not International Units. Use the calculator to convert a dose into the exact draw for your vial and water amount.

Save this protocolPrintable protocol sheet coming soon.